Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 29
Pluvicto patient response criteria validated
By
Will Morton
Doctors now have a reliable approach for determining whether prostate cancer patients are responding to prostate cancer treatment with Pluvicto, according to research published July 11 in
Radiology
.
July 11, 2023
SNMMI calls for clarity over Leqembi PET scans
By
AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imagine (SNMMI) has called for clarity over whether amyloid PET scans will be covered for potential candidates for the new Alzheimer's disease drug Leqembi (lecanemab).
July 10, 2023
FDA grants full approval to Alzheimer's disease drug Leqembi
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted full approval for Eisai and Biogen's Alzheimer's disease drug Leqembi (lecanemab).
July 6, 2023
RaySearch touts selection by Taiwanese hospital
By
AuntMinnie.com staff writers
RaySearch Laboratories is highlighting that the proton therapy machine vendor Sumitomo recently placed an order for the RayStation treatment planning system, which will be installed at the Taichung Veterans General Hospital in Taiwan.
July 6, 2023
F-18 flurpiridaz PET effective in obese patients with CAD
By
Will Morton
A clinical trial of F-18 flurpiridaz PET for detecting coronary artery disease (CAD) met a key outcome by showing effectiveness in obese patients, according to a talk at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
July 4, 2023
Genomic data, tau PET can identify Alzheimer's subtype
By
Erik L. Ridley
The four Alzheimer's disease subtypes can be identified by a computational method that incorporates genomic and tau PET imaging data, according to a study presented at the annual Society of Nuclear Medicine and Molecular Imaging meeting.
July 2, 2023
AI developed for staging patients with prostate cancer
By
Will Morton
An AI model based on prostate-specific membrane antigen-PET/CT imaging performs well in staging prostate cancer patients for surgery, according to a talk at the Society for Nuclear Medicine and Molecular Imaging meeting in Chicago.
July 2, 2023
Canada to invest $26.6M for medical isotope development
By
AuntMinnie.com staff writers
The Canadian government will invest $26.6Â million U.S. toward producing and distributing medical isotopes and radiopharmaceuticals.
June 29, 2023
AuntMinnie.com Molecular Imaging Insider
By
Will Morton
June 29, 2023
PET/CT radiomics help with multiple myeloma prognosis
By
Amerigo Allegretto
Radiomics models based on F-18 FDG-PET/CT imaging features and powered by machine learning can improve prediction for outcomes in multiple myeloma patients, according to research published June 27 in
BMC Medical Imaging
.
June 29, 2023
Imagion expands collaboration with Siemens on MRI contrast agent
By
AuntMinnie.com staff writers
Imagion Biosystems is expanding its collaboration agreement with Siemens Healthineers for an additional two years.
June 28, 2023
SNMMI: PET/MRI shows link between brain receptors and obesity
By
Will Morton
PET/MRI has shown that neuroreceptors in the brains of people with obesity appear to respond differently to food cues those who are not obese, according to research presented June 27 at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 28, 2023
Previous Page
Page 29 of 609
Next Page
